Sponsor Confidentiality Statement:
  template:
    long_name: Enter Sponsor Confidentiality Statement
    short_name: Sponsor Confidentiality Statement
    original_name: Sponsor Confidentiality Statement
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Insert the sponsor’s confidentiality statement, if applicable; otherwise delete.
  technical:
    name: Sponsor Confidentiality Statement
    data_type: Text
    definition:
    - c_code: C181236
      text: A written message within the study protocol that asserts a statement of
        non-disclosure, such that information contained within the protocol document
        may only be shared with authorized parties.
    guidance: Insert the sponsor’s confidentiality statement, if applicable; otherwise
      delete.
    conformance: Optional
    cardinality: One to one
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading
      concept:
        c_code: C181236
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A written message within the study protocol that asserts a statement
          of non-disclosure, such that information contained within the protocol document
          may only be shared with authorized parties.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 1
Full Title:
  template:
    long_name: Enter Full Title
    short_name: Full Title
    original_name: Full Title
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - The protocol should have a descriptive title that identifies the scientific
      aspects of the trial sufficiently to ensure it is immediately evident what the
      trial is investigating and on whom, and to allow retrieval from literature or
      internet searches.
  technical:
    name: Full Title
    data_type: Text
    definition:
    - c_code: C132346
      text: The formal, descriptive name of the protocol.
    guidance: The protocol should have a descriptive title that identifies the scientific
      aspects of the trial sufficiently to ensure it is immediately evident what the
      trial is investigating and on whom, and to allow retrieval from literature or
      internet searches.
    conformance: Required
    cardinality: One to one
    relationship: Title page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C132346
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The formal, descriptive name of the protocol.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 2
Trial Acronym:
  template:
    long_name: Enter Trial Acronym
    short_name: Trial Acronym
    original_name: Trial Acronym
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Acronym or abbreviation used publicly to identify the clinical trial. Delete
      this line from the table if not applicable.
  technical:
    name: Trial Acronym
    data_type: Text
    definition:
    - c_code: C94108
      text: The non-unique initials or abbreviated name used for identification of
        the study protocol document version.
    guidance: Acronym or abbreviation used publicly to identify the clinical trial.
      Delete this line from the table if not applicable.
    conformance: Optional
    cardinality: One to one
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier
      concept:
        c_code: C94108
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The non-unique initials or abbreviated name used for identification
          of the study protocol document version.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 3
Sponsor Protocol Identifier:
  template:
    long_name: Enter Sponsor Protocol Identifier
    short_name: Sponsor Protocol Identifier
    original_name: Sponsor Protocol Identifier
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - A unique alphanumeric identifier for the trial, designated by the sponsor.
  technical:
    name: Sponsor Protocol Identifier
    data_type: Text
    definition:
    - c_code: C132351
      text: A unique code, which is assigned by the sponsor, that identifies a specific
        protocol.
    guidance: A unique alphanumeric identifier for the trial, designated by the sponsor.
    conformance: Required
    cardinality: One to one
    relationship: Title page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading
      concept:
        c_code: C132351
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A unique code, which is assigned by the sponsor, that identifies
          a specific protocol.
      other: 'Note: Must have at least One Character, may not be space (null)'
    repeating: 'No'
    ct: {}
  ordinal: 4
Original Protocol Indicator:
  template:
    long_name: Original Protocol Indicator
    short_name: Original Protocol Indicator
    original_name: Original Protocol Indicator
    optional: false
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Original Protocol Indicator
    data_type: Valid Value
    definition:
    - c_code: C218672
      text: An indication as to whether the protocol document is the original version
        of the protocol.
    guidance: N/A
    conformance: Required
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title page
    value: "Code List C217046: ICH OID 2.16.840.1.113883.3.989.2.3.1.11\n Yes (C49488),\
      \ No (C49487)"
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C218672
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: An indication as to whether the protocol document is the original
          version of the protocol.
      other: ''
    repeating: 'No'
    ct:
      c_code: C217046
      ich_oids:
      - 2.16.840.1.113883.3.989.2.3.1.11
      definition: Terminology associated with the no yes value set codelist of the
        ICH M11 protocol template.
      items:
      - preferred_term: 'Yes'
        c_code: C49488
        definition: The affirmative response to a question.
      - preferred_term: 'No'
        c_code: C49487
        definition: The non-affirmative response to a question.
  ordinal: 5
Version Number:
  template:
    long_name: Enter Version Number
    short_name: Version Number
    original_name: Version Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - For use by the sponsor at their discretion.
  technical:
    name: Version Number
    data_type: Text
    definition:
    - c_code: C181232
      text: A string of numerals that uniquely identifies a specific version of a
        study protocol.
    guidance: For use by the sponsor at their discretion.
    conformance: Optional
    cardinality: One to one, Protocol Identifier
    relationship: Title Page
    value: Number
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C181232
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A string of numerals that uniquely identifies a specific version
          of a study protocol.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 6
Version Date:
  template:
    long_name: Enter Version Date
    short_name: Version Date
    original_name: Version Date
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - For use by the sponsor at their discretion.
  technical:
    name: Version Date
    data_type: Date
    definition:
    - c_code: C93813
      text: The date (and time) on which the document is versioned.
    guidance: For use by the sponsor at their discretion.
    conformance: Optional
    cardinality: One to one; one to Version Number
    relationship: Title page
    value: Date Format
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Version Number; Sponsor Protocol Identifier
      concept:
        c_code: C93813
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The date (and time) on which the document is versioned.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 7
Amendment Identifier:
  template:
    long_name: Amendment Identifier
    short_name: Amendment Identifier
    original_name: Amendment Identifier
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - Enter the amendment identifier (e.g., amendment number). If this is the original
      instance of the protocol, delete this row or enter "Not applicable".
  technical:
    name: Amendment Identifier
    data_type: Text
    definition:
    - c_code: C218477
      text: A sequence of characters used to uniquely identify a protocol amendment.
    guidance: Enter the amendment identifier (e.g., amendment number). If this is
      the original instance of the protocol, delete this row or enter "Not applicable"
    conformance: 'Conditional: when there is an amendment'
    cardinality: One to one; One to Protocol Identifier if not original
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: Yes if Original Protocol = No; blank if Original Protocol = Yes
      relationship: Heading, Sponsor Protocol Identifier
      concept:
        c_code: C218477
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.12
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to uniquely identify a protocol
          amendment.
      other: ''
    repeating: Yes, repeatable for Table for Document History
    ct: {}
  ordinal: 8
Amendment Scope:
  template:
    long_name: Amendment Scope
    short_name: Amendment Scope
    original_name: Amendment Scope
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - If this is the original instance of the protocol, delete this row or enter "Not
      applicable". For an amendment that applies to all sites in the trial, enter
      “Global” and delete the Country, Region and Site Identifier fields. If amending
      a single-country trial, enter “Global”.
    - For an amendment that does not apply to all sites in the trial, select “Not
      Global” and utilise one of the identifiers based on amendment scope.
  technical:
    name: Amendment Scope
    data_type: Valid Value
    definition:
    - c_code: C218673
      text: A descriptive indicator of whether the amendment scope applies globally
        across the trial.
    guidance: If this is the original instance of the protocol, delete this row or
      enter "Not applicable". For an amendment that applies to all sites in the trial,
      enter “Global” and delete the Country, Region and Site Identifier fields. If
      amending a single-country trial, enter “Global”.
    conformance: 'Conditional: when there is an amendment'
    cardinality: One to one, One to Amendment Identifier
    relationship: Title page
    value: "Code List C217047: ICH OID 2.16.840.1.113883.3.989.2.3.1.3\nBlank; Global\
      \ (C68846), \nNot Global (C217026)"
    business_rules:
      value_allowed: 'Yes; if Original Protocol = No; blank if Original Protocol =
        Yes Relationship: Heading, Amendment Identifier, Sponsor Protocol Identifier'
      relationship: ''
      concept:
        c_code: C218673
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A descriptive indicator of whether the amendment scope applies
          globally across the trial.
      other: ''
    repeating: 'No'
    ct:
      c_code: C217047
      ich_oids:
      - 2.16.840.1.113883.3.989.2.3.1.3
      definition: Terminology associated with the amendment scope value set codelist
        of the ICH M11 protocol template.
      items:
      - preferred_term: Global
        c_code: C68846
        definition: Covering or affecting the whole of a system.
      - preferred_term: Not Global
        c_code: C217026
        definition: Covering or affecting only a portion of the entire system.
  ordinal: 9
Country Identifier:
  template:
    long_name: Country Identifier
    short_name: Country Identifier
    original_name: Country Identifier
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - If this is the original instance of the protocol, delete this row or enter "Not
      applicable". For an amendment that applies to all sites in the trial, enter
      “Global” and delete the Country, Region and Site Identifier fields. If amending
      a single-country trial, enter “Global”.
    - For an amendment that does not apply to all sites in the trial, select “Not
      Global” and utilise one of the identifiers based on amendment scope.
  technical:
    name: Country Identifier
    data_type: Valid Value
    definition:
    - c_code: C20108
      text: An alphanumeric system designed to identify countries. The ISO 3166 standard
        includes a two letter representation, a three letter representation, and a
        3 number representation. The last two are identical to the UN system. The
        US State Department system maintains a separate two letter representation
        code set.
    - c_code: C218674
      text: A sequence of characters used to identify and/or name the region.
    - c_code: C83081
      text: A sequence of characters used to identify, name, or characterize the study
        site.
    - c_code: C20108
      text: An alphanumeric system designed to identify countries. The ISO 3166 standard
        includes a two letter representation, a three letter representation, and a
        3 number representation. The last two are identical to the UN system. The
        US State Department system maintains a separate two letter representation
        code set.
    - c_code: C218674
      text: A sequence of characters used to identify and/or name the region.
    - c_code: C83081
      text: A sequence of characters used to identify, name, or characterize the study
        site.
    guidance: For an amendment that does not apply to all sites in the trial, select
      “Not Global” and utilise one of the identifiers based on amendment scope.
    conformance: 'Conditional: when Amendment scope is not global'
    cardinality: One to one; Many to Amendment Scope; One to Amendment Identifier;
      One to Sponsor Protocol Identifier
    relationship: Title Page
    value: 'Country specific: [Country Identifier] (ISO 3166 Country Codes, Alpha
      3; ISO 3166 Country Codes, Alpha 2; GENC)

      or

      Region Specific: [Region Identifier] (ISO 3166 Region Codes, Alpha 3; ISO 3166
      Region Codes, Alpha 2; GENC)

      or

      Site specific: [Site Identifier] (Text)

      Site Identifier Text

      Conditional Blank for Original Protocol Indicator = yes'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading, Amendment Scope, Amendment Identifier, Sponsor Protocol
        Identifier
      concept:
        c_code: C20108
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: An alphanumeric system designed to identify countries. The ISO
          3166 standard includes a two letter representation, a three letter representation,
          and a 3 number representation. The last two are identical to the UN system.
          The US State Department system maintains a separate two letter representation
          code set.
      other: ''
    repeating: Yes, repeatable in 12.2 Country/Region-Specific Differences
    ct: {}
  ordinal: 10
Region Identifier:
  template:
    long_name: Region Identifier
    short_name: Region Identifier
    original_name: Region Identifier
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - If this is the original instance of the protocol, delete this row or enter "Not
      applicable". For an amendment that applies to all sites in the trial, enter
      “Global” and delete the Country, Region and Site Identifier fields. If amending
      a single-country trial, enter “Global”.
    - For an amendment that does not apply to all sites in the trial, select “Not
      Global” and utilise one of the identifiers based on amendment scope.
  technical:
    name: Region Identifier
    data_type: Valid Value
    definition:
    - c_code: C20108
      text: An alphanumeric system designed to identify countries. The ISO 3166 standard
        includes a two letter representation, a three letter representation, and a
        3 number representation. The last two are identical to the UN system. The
        US State Department system maintains a separate two letter representation
        code set.
    - c_code: C218674
      text: A sequence of characters used to identify and/or name the region.
    - c_code: C83081
      text: A sequence of characters used to identify, name, or characterize the study
        site.
    - c_code: C20108
      text: An alphanumeric system designed to identify countries. The ISO 3166 standard
        includes a two letter representation, a three letter representation, and a
        3 number representation. The last two are identical to the UN system. The
        US State Department system maintains a separate two letter representation
        code set.
    - c_code: C218674
      text: A sequence of characters used to identify and/or name the region.
    - c_code: C83081
      text: A sequence of characters used to identify, name, or characterize the study
        site.
    guidance: For an amendment that does not apply to all sites in the trial, select
      “Not Global” and utilise one of the identifiers based on amendment scope.
    conformance: 'Conditional: when Amendment scope is not global'
    cardinality: One to one; Many to Amendment Scope; One to Amendment Identifier;
      One to Sponsor Protocol Identifier
    relationship: Title Page
    value: 'Country specific: [Country Identifier] (ISO 3166 Country Codes, Alpha
      3; ISO 3166 Country Codes, Alpha 2; GENC)

      or

      Region Specific: [Region Identifier] (ISO 3166 Region Codes, Alpha 3; ISO 3166
      Region Codes, Alpha 2; GENC)

      or

      Site specific: [Site Identifier] (Text)

      Site Identifier Text

      Conditional Blank for Original Protocol Indicator = yes'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading, Amendment Scope, Amendment Identifier, Sponsor Protocol
        Identifier
      concept:
        c_code: C20108
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: An alphanumeric system designed to identify countries. The ISO
          3166 standard includes a two letter representation, a three letter representation,
          and a 3 number representation. The last two are identical to the UN system.
          The US State Department system maintains a separate two letter representation
          code set.
      other: ''
    repeating: Yes, repeatable in 12.2 Country/Region-Specific Differences
    ct: {}
  ordinal: 11
Site Identifier:
  template:
    long_name: Enter Site Identifier
    short_name: Site Identifier
    original_name: Site Identifier
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - If this is the original instance of the protocol, delete this row or enter "Not
      applicable". For an amendment that applies to all sites in the trial, enter
      “Global” and delete the Country, Region and Site Identifier fields. If amending
      a single-country trial, enter “Global”.
    - For an amendment that does not apply to all sites in the trial, select “Not
      Global” and utilise one of the identifiers based on amendment scope.
  technical:
    name: Site Identifier
    data_type: Valid Value
    definition:
    - c_code: C20108
      text: An alphanumeric system designed to identify countries. The ISO 3166 standard
        includes a two letter representation, a three letter representation, and a
        3 number representation. The last two are identical to the UN system. The
        US State Department system maintains a separate two letter representation
        code set.
    - c_code: C218674
      text: A sequence of characters used to identify and/or name the region.
    - c_code: C83081
      text: A sequence of characters used to identify, name, or characterize the study
        site.
    - c_code: C20108
      text: An alphanumeric system designed to identify countries. The ISO 3166 standard
        includes a two letter representation, a three letter representation, and a
        3 number representation. The last two are identical to the UN system. The
        US State Department system maintains a separate two letter representation
        code set.
    - c_code: C218674
      text: A sequence of characters used to identify and/or name the region.
    - c_code: C83081
      text: A sequence of characters used to identify, name, or characterize the study
        site.
    guidance: For an amendment that does not apply to all sites in the trial, select
      “Not Global” and utilise one of the identifiers based on amendment scope.
    conformance: 'Conditional: when Amendment scope is not global'
    cardinality: One to one; Many to Amendment Scope; One to Amendment Identifier;
      One to Sponsor Protocol Identifier
    relationship: Title Page
    value: 'Country specific: [Country Identifier] (ISO 3166 Country Codes, Alpha
      3; ISO 3166 Country Codes, Alpha 2; GENC)

      or

      Region Specific: [Region Identifier] (ISO 3166 Region Codes, Alpha 3; ISO 3166
      Region Codes, Alpha 2; GENC)

      or

      Site specific: [Site Identifier] (Text)

      Site Identifier Text

      Conditional Blank for Original Protocol Indicator = yes'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading, Amendment Scope, Amendment Identifier, Sponsor Protocol
        Identifier
      concept:
        c_code: C20108
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: An alphanumeric system designed to identify countries. The ISO
          3166 standard includes a two letter representation, a three letter representation,
          and a 3 number representation. The last two are identical to the UN system.
          The US State Department system maintains a separate two letter representation
          code set.
      other: ''
    repeating: Yes, repeatable in 12.2 Country/Region-Specific Differences
    ct: {}
  ordinal: 12
Sponsors Investigational Product Codes:
  template:
    long_name: Enter Sponsor’s Investigational Product Code(s)
    short_name: Sponsors Investigational Product Codes
    original_name: Sponsor’s Investigational Product Code(s)
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Enter the sponsor’s unique identifier for investigational product(s) in the
      trial. Add fields as needed.
  technical:
    name: Sponsors Investigational Product Codes
    data_type: Text
    definition:
    - c_code: C218675
      text: A symbol or combination of symbols that are assigned by the sponsor to
        uniquely identify an experimental intervention.
    guidance: Enter the sponsor’s unique identifier for investigational product(s)
      in the trial. Add fields as needed.
    conformance: 'Optional: if there is Sponsor Investigational Product Code'
    cardinality: One to one, Many to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C218675
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A symbol or combination of symbols that are assigned by the sponsor
          to uniquely identify an experimental intervention.
      other: ''
    repeating: 'Yes, repeatable for each Investigational compound

      Yes, repeatable in 1.1.2 under Intervention'
    ct: {}
  ordinal: 13
Nonproprietary Names:
  template:
    long_name: Enter Nonproprietary Name(s)
    short_name: Nonproprietary Names
    original_name: Nonproprietary Name(s)
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Nonproprietary Names
    data_type: Text
    definition:
    - c_code: C97054
      text: A non-branded or registered name that meant for common use.
    guidance: Omit nonproprietary name field if a nonproprietary name has not yet
      been assigned.
    conformance: Optional
    cardinality: One to many; Many to Sponsor Investigational Product Code(s); Many
      to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text Use for example WHO INN, USAN, JAN, XEVMPD
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading, Sponsor Protocol Identifier
      concept:
        c_code: C97054
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A non-branded or registered name that meant for common use.
      other: ''
    repeating: "Yes, repeatable for each nonproprietary name \nYes, repeatable in\
      \ 1.1.2 under intervention"
    ct: {}
  ordinal: 14
Proprietary Names:
  template:
    long_name: Enter Proprietary Name(s)
    short_name: Proprietary Names
    original_name: Proprietary Name(s)
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Omit nonproprietary name field if a nonproprietary name has not yet been assigned.
      Omit proprietary name field if not yet established.
  technical:
    name: Proprietary Names
    data_type: Text
    definition:
    - c_code: C71898
      text: The part of the name or logo associated with a specific product or service
        identifying and distinguishing it from varieties of the same product or service
        marketed by competing companies.
    guidance: Omit proprietary name field if not yet established.
    conformance: Optional; Blank
    cardinality: One to many; Many to Sponsor Investigational Product Code(s); Many
      to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier; Compound Code
      concept:
        c_code: C71898
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The part of the name or logo associated with a specific product
          or service identifying and distinguishing it from varieties of the same
          product or service marketed by competing companies.
      other: ''
    repeating: Yes, repeatable for each proprietary name
    ct: {}
  ordinal: 15
Trial Phase:
  template:
    long_name: Trial Phase
    short_name: Trial Phase
    original_name: Trial Phase
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - For trials combining investigational drugs or vaccines with devices, classify
      according to the phase of drug development.
  technical:
    name: Trial Phase
    data_type: Valid Value
    definition:
    - c_code: C48281
      text: 'Clinical trials are broken into three or four phases: Phase I tests a
        new drug or treatment for safety in a small group; Phase II expands the study
        to a larger group of people; Phase III expands the study to an even larger
        group of people to measure whether the treatment actually benefits patients,
        and whether its benefits exceed its risks; and Phase IV takes place after
        the drug or treatment has been licensed and marketed.'
    guidance: For trials combining investigational drugs or vaccines with devices,
      classify according to the phase of drug development.
    conformance: Required
    cardinality: One to one; Sponsor Protocol Identifier
    relationship: Title Page
    value: 'Code List C217045: ICH OID 2.16.840.1.113883.3.989.2.3.1.18

      Early Phase 1 (C54721); Phase 1 (C15600); Phase 1/Phase 2 (C15693); Phase 1/Phase
      2/Phase 3 (C198366); Phase 1/Phase 3 (C198367); Phase 2 (C15601); Phase 2/Phase
      3 (C15694); Phase 2/Phase 3/Phase 4 (C217024); Phase 3 (C15602); Phase 3/Phase
      4 (C217025); Phase 4 (C15603)'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C48281
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: 'Clinical trials are broken into three or four phases: Phase I
          tests a new drug or treatment for safety in a small group; Phase II expands
          the study to a larger group of people; Phase III expands the study to an
          even larger group of people to measure whether the treatment actually benefits
          patients, and whether its benefits exceed its risks; and Phase IV takes
          place after the drug or treatment has been licensed and marketed.'
      other: ''
    repeating: 'No'
    ct:
      c_code: C217045
      ich_oids:
      - 2.16.840.1.113883.3.989.2.3.1.18
      definition: Terminology associated with the trial phase value set codelist of
        the ICH M11 protocol template.
      items:
      - preferred_term: Early Phase 1
        c_code: C54721
        definition: A clinical trial that uses an investigational agent that is available
          only in very limited quantities and which has never previously given to
          humans or for which there is extremely limited human experience. Phase 0
          clinical trials are intended to enable researchers to understand the path
          of the drug in the body and its efficacy. Adverse event reporting in Phase
          0 trials is expedited.
      - preferred_term: Phase 1
        c_code: C15600
        definition: A clinical research protocol designed to test a new biomedical
          intervention in a small group of people for the first time. A Phase I trial
          can be to establish the toxicity of a new treatment with escalating intensity
          of the treatment administered and/or to determine the side effects of a
          new treatment for a particular indication in subjects.
      - preferred_term: Phase 1/Phase 2
        c_code: C15693
        definition: A clinical research protocol designed to study the safety, dosage
          levels and response to new treatment. Phase I/II trials combine a Phase
          I and a Phase II trial of the same treatment into a single protocol.
      - preferred_term: Phase 1/Phase 2/Phase 3
        c_code: C198366
        definition: A study that begins as a Phase I study and transitions into Phases
          II and III based upon successful completion of each previous portion.
      - preferred_term: Phase 1/Phase 3
        c_code: C198367
        definition: A study that begins as a Phase I study and transitions into a
          Phase III study upon successful completion of the Phase I portion.
      - preferred_term: Phase 2
        c_code: C15601
        definition: A clinical research protocol designed to study a biomedical or
          behavioral intervention in a larger group of people (several hundred), to
          evaluate the drug's effectiveness for a particular indication in patients
          with the disease or condition under study, and to determine the common short-term
          side effects and risks associated with the intervention.
      - preferred_term: Phase 2/Phase 3
        c_code: C15694
        definition: A type of clinical study that combines elements characteristic
          of traditional Phase II and Phase III trials.
      - preferred_term: Phase 2/Phase 3/Phase 4
        c_code: C217024
        definition: A study that begins as a Phase II study and transitions into Phases
          III and IV based upon successful completion of each previous portion.
      - preferred_term: Phase 3
        c_code: C15602
        definition: A clinical research protocol designed to investigate the efficacy
          of the biomedical or behavioral intervention in large groups of human subjects
          (from several hundred to several thousand), to confirm efficacy, to monitor
          adverse reactions to the new medication or treatment regimen with respect
          to long-term use and by comparing the intervention to other standard or
          experimental interventions as well as to a placebo.
      - preferred_term: Phase 3/Phase 4
        c_code: C217025
        definition: A type of clinical study that combines elements characteristic
          of traditional Phase III and Phase IV trials.
      - preferred_term: Phase 4
        c_code: C15603
        definition: A randomized, controlled trial that is designed to evaluate the
          long-term safety and efficacy of a drug for a given indication. Often they
          are designed to study side effects that may have become apparent after the
          phase III study was completed.
  ordinal: 16
Trial Short Title:
  template:
    long_name: Enter Trial Short Title
    short_name: Trial Short Title
    original_name: Trial Short Title
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Short title should convey in plain language what the trial is about and should
      be suitable for use as “Brief Title” or “Title in Plain Language” in global
      clinical trial registries. It can also be suitable for use with informed consent
      forms (ICFs) and ethics committee submissions.
  technical:
    name: Trial Short Title
    data_type: Text
    definition:
    - c_code: C94105
      text: The brief title of the protocol document, that is intended for the general
        population.
    guidance: Short title should convey in plain language what the trial is about
      and should be suitable for use as “Brief Title” or “Title in Plain Language”
      in global clinical trial registries. It can also be suitable for use with informed
      consent forms (ICF) and ethics committee submissions.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C94105
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The brief title of the protocol document, that is intended for
          the general population.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 17
Sponsor Name:
  template:
    long_name: Enter Sponsor Name
    short_name: Sponsor Name
    original_name: Sponsor Name
    optional: false
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Sponsor Name
    data_type: Text
    definition:
    - c_code: C222495
      text: The literal identifier (i.e., distinctive designation) of the trial sponsor.
    guidance: 'Provide the legal name and address of the individual or pharmaceutical
      or medical device company, governmental agency, academic institution, private
      organisation, or other organisation who takes primary responsibility for and
      initiates a clinical investigation. If more than one sponsor, list the primary
      sponsor in the Sponsor Name and Sponsor Legal Address fields.

      If co-sponsor is applicable, enter co-sponsor name and legal address. Add additional
      fields if more than one co-sponsor is applicable.'
    conformance: Required
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C222495
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The literal identifier (i.e., distinctive designation) of the
          trial sponsor.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 18
Sponsor Legal Address:
  template:
    long_name: Enter Sponsor Legal Address
    short_name: Sponsor Legal Address
    original_name: Sponsor Legal Address
    optional: false
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Sponsor Legal Address
    data_type: Text
    definition:
    - c_code: C222495
      text: The literal identifier (i.e., distinctive designation) of the trial sponsor.
    guidance: 'Provide the legal name and address of the individual or pharmaceutical
      or medical device company, governmental agency, academic institution, private
      organisation, or other organisation who takes primary responsibility for and
      initiates a clinical investigation. If more than one sponsor, list the primary
      sponsor in the Sponsor Name and Sponsor Legal Address fields.

      If co-sponsor is applicable, enter co-sponsor name and legal address. Add additional
      fields if more than one co-sponsor is applicable.'
    conformance: Required
    cardinality: One to one; One to Sponsor Name
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Name
      concept:
        c_code: C222495
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The literal identifier (i.e., distinctive designation) of the
          trial sponsor.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 19
Co-Sponsor Name:
  template:
    long_name: Enter Co-Sponsor Name
    short_name: Co-Sponsor Name
    original_name: Co-Sponsor Name
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Co-Sponsor Name
    data_type: Text
    definition:
    - c_code: C218678
      text: The literal identifier (i.e., distinctive designation) of the trial co-sponsor.
    guidance: 'Provide the legal name and address of the individual or pharmaceutical
      or medical device company, governmental agency, academic institution, private
      organisation, or other organisation who takes primary responsibility for and
      initiates a clinical investigation. If more than one sponsor, list the primary
      sponsor in the Sponsor Name and Sponsor Legal Address fields.

      If co-sponsor is applicable, enter co-sponsor name and legal address. Add additional
      fields if more than one co-sponsor is applicable.'
    conformance: Optional
    cardinality: One to one; One to Co-Sponsor Name; One to Sponsor Name; One to Sponsor
      Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Co-Sponsor Name; Sponsor Name; Protocol Identifier
      concept:
        c_code: C218678
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The literal identifier (i.e., distinctive designation) of the
          trial co-sponsor.
      other: ''
    repeating: 'Yes.

      Repeat for each Co-Sponsor Name'
    ct: {}
  ordinal: 20
Co-Sponsor Legal Address:
  template:
    long_name: Enter Co-Sponsor Legal Address
    short_name: Co-Sponsor Legal Address
    original_name: Co-Sponsor Legal Address
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Provide the legal name and address of the individual or pharmaceutical or medical
      device company, governmental agency, academic institution, private organisation,
      or other organisation who takes primary responsibility for and initiates a clinical
      investigation. If more than one sponsor, list the primary sponsor in the Sponsor
      Name and Sponsor Legal Address fields.
    - If co-sponsor is applicable, enter co-sponsor name and legal address. Add additional
      fields if more than one co-sponsor is applicable.
  technical:
    name: Co-Sponsor Legal Address
    data_type: Text
    definition:
    - c_code: C218679
      text: The legally registered address of the trial co-sponsor.
    guidance: 'Provide the legal name and address of the individual or pharmaceutical
      or medical device company, governmental agency, academic institution, private
      organisation, or other organisation who takes primary responsibility for and
      initiates a clinical investigation. If more than one sponsor, list the primary
      sponsor in the Sponsor Name and Sponsor Legal Address fields.

      If co-sponsor is applicable, enter co-sponsor name and legal address. Add additional
      fields if more than one co-sponsor is applicable.'
    conformance: Optional
    cardinality: One to one; One to Heading; One to Co-Sponsor Name
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Co-Sponsor Name
      concept:
        c_code: C218679
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The legally registered address of the trial co-sponsor.
      other: ''
    repeating: "Yes \nRepeat for each associated Co-Sponsor Legal Address. There is\
      \ only one Co-Sponsor Legal Address for each Co-Sponsor Name."
    ct: {}
  ordinal: 21
Local Sponsor Name:
  template:
    long_name: Enter Local Sponsor Name
    short_name: Local Sponsor Name
    original_name: Local Sponsor Name
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Local Sponsor Name
    data_type: Text
    definition:
    - c_code: C218680
      text: The literal identifier (i.e., distinctive designation) of the sponsor's
        legal representative at a geographical region within which the sponsor has
        no legal presence.
    guidance: In some countries, the clinical trial Sponsor may be the local affiliate
      company (or designee). In such cases, indicate this in the Local Sponsor Name
      and Address Field.
    conformance: Optional
    cardinality: One to one; One to Sponsor Name and Address; Many to Sponsor Name
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Name and Address; Sponsor Name; Country
      concept:
        c_code: C218680
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The literal identifier (i.e., distinctive designation) of the
          sponsor's legal representative at a geographical region within which the
          sponsor has no legal presence.
      other: ''
    repeating: Yes, repeatable for each Local Sponsor Name
    ct: {}
  ordinal: 22
Local Sponsor Legal Address:
  template:
    long_name: Enter Local Sponsor Legal Address
    short_name: Local Sponsor Legal Address
    original_name: Local Sponsor Legal Address
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - In some countries, the clinical trial sponsor may be the local affiliate company
      (or designee). In such cases, indicate this in the Local Sponsor Name and Local
      Sponsor Legal Address Fields.
  technical:
    name: Local Sponsor Legal Address
    data_type: Text
    definition:
    - c_code: C218681
      text: The legally registered address of the sponsor's legal representative at
        a geographical region within which the sponsor has no legal presence.
    guidance: In some countries, the clinical trial sponsor may be the local affiliate
      company (or designee). In such cases, indicate this in the Local Sponsor Name
      and Local Sponsor Legal Address Fields.
    conformance: Optional
    cardinality: One to one; One to Local Sponsor; One to Country
    relationship: Title page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Local Sponsor; Country
      concept:
        c_code: C218681
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The legally registered address of the sponsor's legal representative
          at a geographical region within which the sponsor has no legal presence.
      other: ''
    repeating: 'Yes

      Repeat for each associated Local Sponsor Name. There is only one Address for
      each Local Sponsor Name'
    ct: {}
  ordinal: 23
Device Manufacturer Name:
  template:
    long_name: Enter Device Manufacturer Name
    short_name: Device Manufacturer Name
    original_name: Device Manufacturer Name
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: Device Manufacturer Name
    data_type: Text
    definition:
    - c_code: C218682
      text: The literal identifier (i.e., distinctive designation) of the organization
        defined as being responsible for creating the device as stated on the package
        in which the product is supplied.
    guidance: 'Manufacturer name and address information is required only for drug/device
      combination protocols that include investigational device(s) and should not
      be included for other protocols. Include the manufacturer address only if the
      manufacturer is different than the sponsor listed above.

      Add additional fields as needed if multiple investigational devices will be
      used in the trial or if there are multiple manufacturers for a single device.
      Delete this line if not applicable.'
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier; One to Sponsor Name
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier; Sponsor Name
      concept:
        c_code: C218682
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The literal identifier (i.e., distinctive designation) of the
          organization defined as being responsible for creating the device as stated
          on the package in which the product is supplied.
      other: ''
    repeating: Yes, repeatable for each Device Manufacturers
    ct: {}
  ordinal: 24
Device Manufacturer Legal Address:
  template:
    long_name: Enter Device Manufacturer Legal Address
    short_name: Device Manufacturer Legal Address
    original_name: Device Manufacturer Legal Address
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Manufacturer name and address information is required only for drug/device combination
      protocols that include investigational device(s) and should not be included
      for other protocols. Include the manufacturer address only if the manufacturer
      is different than the sponsor listed above.
    - Add additional fields as needed if multiple investigational devices will be
      used in the trial or if there are multiple manufacturers for a single device.
      Delete this line if not applicable.
  technical:
    name: Device Manufacturer Legal Address
    data_type: Text
    definition:
    - c_code: C218683
      text: The legally registered address of the device manufacturer.
    guidance: 'Manufacturer name and address information is required only for drug/device
      combination protocols that include investigational device(s) and should not
      be included for other protocols. Include the manufacturer address only if the
      manufacturer is different than the sponsor listed above.

      Add additional fields as needed if multiple investigational devices will be
      used in the trial or if there are multiple manufacturers for a single device.
      Delete this line if not applicable.'
    conformance: Optional
    cardinality: One to one; One to Device Manufacturer Name
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Device Manufacturing Name
      concept:
        c_code: C218683
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The legally registered address of the device manufacturer.
      other: ''
    repeating: Yes. Repeatable for each associated Device Manufacturer Name. There
      is only one Device Manufacturer Address for each associated Device Manufacturer
      Name
    ct: {}
  ordinal: 25
EU CT Number:
  template:
    long_name: EU CT Number
    short_name: EU CT Number
    original_name: EU CT Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: EU CT Number
    data_type: Text
    definition:
    - c_code: C218684
      text: A sequence of characters used to identify a clinical trial, as assigned
        by the Clinical Trials Information System (CTIS) of the European Medicines
        Agency.
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes; EU CT number: yyyy-5xxxxx-xx with YYYY corresponding to
        a year i.e. 2024 and x being an integer'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C218684
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to identify a clinical trial, as
          assigned by the Clinical Trials Information System (CTIS) of the European
          Medicines Agency.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 26
FDA IND Number:
  template:
    long_name: FDA IND Number
    short_name: FDA IND Number
    original_name: FDA IND Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: FDA IND Number
    data_type: Text
    definition:
    - c_code: C218685
      text: A sequence of characters used to identify a clinical trial under an Investigational
        New Drug (IND) application, as assigned by the US Food and Drug Administration.
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier
      concept:
        c_code: C218685
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to identify a clinical trial under
          an Investigational New Drug (IND) application, as assigned by the US Food
          and Drug Administration.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 27
IDE Number:
  template:
    long_name: IDE Number
    short_name: IDE Number
    original_name: IDE Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: IDE Number
    data_type: Text
    definition:
    - c_code: C218686
      text: A sequence of characters used to identify a clinical trial under an Investigational
        Device Exemption (IDE) application, as assigned by the US Food and Drug Administration.
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier
      concept:
        c_code: C218686
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to identify a clinical trial under
          an Investigational Device Exemption (IDE) application, as assigned by the
          US Food and Drug Administration.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 28
jRCT Number:
  template:
    long_name: jRCT Number
    short_name: jRCT Number
    original_name: jRCT Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: jRCT Number
    data_type: Text
    definition:
    - c_code: C218687
      text: A sequence of characters used to identify a clinical trial, as assigned
        by the Japan Registry for Clinical Trials (JRCT) of the Ministry of Health,
        Labour and Welfare (MHLW) in Japan.
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier
      concept:
        c_code: C218687
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to identify a clinical trial, as
          assigned by the Japan Registry for Clinical Trials (JRCT) of the Ministry
          of Health, Labour and Welfare (MHLW) in Japan.
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 29
NCT Number:
  template:
    long_name: NCT Number
    short_name: NCT Number
    original_name: NCT Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: NCT Number
    data_type: Text
    definition:
    - c_code: C172240
      text: The unique alphanumeric identifier for a trial as assigned by the Clinicaltrials.gov
        Protocol Registration and Results System (PRS).
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C172240
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The unique alphanumeric identifier for a trial as assigned by
          the Clinicaltrials.gov Protocol Registration and Results System (PRS).
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 30
NMPA IND Number:
  template:
    long_name: NMPA IND Number
    short_name: NMPA IND Number
    original_name: NMPA IND Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: NMPA IND Number
    data_type: Text
    definition:
    - c_code: C218688
      text: A sequence of characters used to identify a clinical trial under an Investigational
        New Drug (IND) application, as assigned by the Chinese National Medicinal
        Products Administration (NMPA).
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C218688
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to identify a clinical trial under
          an Investigational New Drug (IND) application, as assigned by the Chinese
          National Medicinal Products Administration (NMPA).
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 31
WHO-UTN Number:
  template:
    long_name: WHO/UTN Number
    short_name: WHO-UTN Number
    original_name: WHO/UTN Number
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: WHO-UTN Number
    data_type: Text
    definition:
    - c_code: C218689
      text: A sequence of characters used to identify a clinical trial, as assigned
        by the World Health organization's International Clinical Trial's Registry
        Platform (ICTRP).
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: 'UTN/WHO: Uxxxx-xxxx-xxxx with X being an integer'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C218689
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters used to identify a clinical trial, as
          assigned by the World Health organization's International Clinical Trial's
          Registry Platform (ICTRP).
      other: ''
    repeating: 'No'
    ct: {}
  ordinal: 32
Other Regulatory or Clinical Trial Identifier:
  template:
    long_name: Other Regulatory or Clinical Trial Identifier
    short_name: Other Regulatory or Clinical Trial Identifier
    original_name: Other Regulatory or Clinical Trial Identifier
    optional: true
    section_number: ''
    section_title: Title Page
    instructions:
    - Include all identifiers that are applicable for the trial and available at the
      time of protocol or amendment finalisation. Delete prompts for identifiers not
      available at the time of document finalisation. Delete unused fields. Add fields
      for “other” if more than one is needed.
  technical:
    name: Other Regulatory or Clinical Trial Identifier
    data_type: Text
    definition:
    - c_code: C218690
      text: A sequence of characters assigned by a regulatory agency or other health
        authority that is used to identify a clinical trial, and that is different
        than the one(s) previously specified or mentioned.
    guidance: Include all identifiers that are applicable for the trial and available
      at the time of protocol or amendment finalisation. Delete prompts for identifiers
      not available at the time of document finalisation. Delete unused fields. Add
      fields for “other” if more than one is needed.
    conformance: Optional
    cardinality: One to one; One to Sponsor Protocol Identifier
    relationship: Title Page
    value: Text
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Sponsor Protocol Identifier
      concept:
        c_code: C218690
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A sequence of characters assigned by a regulatory agency or other
          health authority that is used to identify a clinical trial, and that is
          different than the one(s) previously specified or mentioned.
      other: ''
    repeating: Yes, repeatable for each regulatory agency identifier
    ct: {}
  ordinal: 33
Sponsor Approval Date:
  template:
    long_name: Enter Sponsor Approval Date
    short_name: Sponsor Approval Date
    original_name: Sponsor Approval Date
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - 'All versions should be uniquely identifiable. '
  technical:
    name: Sponsor Approval Date
    data_type: Date or Text
    definition:
    - c_code: C132352
      text: Date protocol that was finalized or approved internally by the sponsor.
    - c_code: C218484
      text: The physical or virtual location of the date on which the sponsor approved
        the current version of the protocol.
    guidance: All versions should be uniquely identifiable.
    conformance: Required
    cardinality: One to one; One to Protocol Identifier; One to Original Protocol
      One to Amendment Identifier
    relationship: Title Page
    value: 'Sponsor Approval Date is a date

      Location where sponsor approval information can be found is text'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier; Protocol Amendment
      concept:
        c_code: C132352
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: Date protocol that was finalized or approved internally by the
          sponsor.
      other: ''
    repeating: "Yes, \nNot repeatable\nreuse to Sponsor Approval Date in Section 12.3"
    ct: {}
  ordinal: 34
State location where sponsor approval information can be found:
  template:
    long_name: State location where sponsor approval information can be found
    short_name: State location where sponsor approval information can be found
    original_name: State location where sponsor approval information can be found
    optional: false
    section_number: ''
    section_title: Title Page
    instructions:
    - 'All versions should be uniquely identifiable. '
  technical:
    name: State location where sponsor approval information can be found
    data_type: Date or Text
    definition:
    - c_code: C132352
      text: Date protocol that was finalized or approved internally by the sponsor.
    - c_code: C218484
      text: The physical or virtual location of the date on which the sponsor approved
        the current version of the protocol.
    guidance: All versions should be uniquely identifiable.
    conformance: Required
    cardinality: One to one; One to Protocol Identifier; One to Original Protocol
      One to Amendment Identifier
    relationship: Title Page
    value: 'Sponsor Approval Date is a date

      Location where sponsor approval information can be found is text'
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading; Protocol Identifier; Protocol Amendment
      concept:
        c_code: C132352
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: Date protocol that was finalized or approved internally by the
          sponsor.
      other: ''
    repeating: "Yes, \nNot repeatable\nreuse to Sponsor Approval Date in Section 12.3"
    ct: {}
  ordinal: 35
Signatory Location:
  template:
    long_name: State location where sponsor signatory information can be found (e.g.,
      electronic signature)
    short_name: Signatory Location
    original_name: State location where sponsor signatory information can be found
      (e.g., electronic signature)
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: state location where sponsor signatory information can be found eg electronic
      signature
    data_type: Image and/or Text
    definition:
    - c_code: C222014
      text: A block of text containing the name and signature of the sponsor's signatory,
        along with the signature date.
    - c_code: C222064
      text: The physical or virtual location of the sponsor signatory information.
    guidance: N/A
    conformance: Optional
    cardinality: One to one
    relationship: Title Page
    value: "Sponsor Signatory Text and/or Image\nOR \nLocation where Sponsor Signatory\
      \ information can be found (Text)"
    business_rules:
      value_allowed: 'Yes'
      relationship: Heading
      concept:
        c_code: C222014
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: A block of text containing the name and signature of the sponsor's
          signatory, along with the signature date.
      other: ''
    repeating: 'No'
    ct: {}
    short_name: Signatory Location
  ordinal: 36
Medical Expert Contact Info:
  template:
    long_name: Enter Medical Expert contact information (as designated by sponsor)
    short_name: Medical Expert Contact Info
    original_name: Medical Expert contact information (as designated by sponsor)
    optional: true
    section_number: ''
    section_title: Title Page
    instructions: []
  technical:
    name: state location where Medical Expert contact information can be found
    data_type: Text
    definition:
    - c_code: C218693
      text: The contact information for the sponsor's representative who can advise
        on specific trial-related medical questions or problems.
    - c_code: C222063
      text: The physical or virtual location of the medical expert (as designated
        by the sponsor) contact information.
    guidance: N/A
    conformance: Optional
    cardinality: One to one;
    relationship: Title Page
    value: "Medical Expert contact information (Text)\nOR \nLocation where Medical\
      \ Expert contact information can be found (Text)"
    business_rules:
      value_allowed: 'Yes'
      relationship: Medical Expert Contact Response
      concept:
        c_code: C218693
        ich_oids:
        - 2.16.840.1.113883.3.989.2.3.3.16
        - 2.16.840.1.113883.3.989.2.3.3.16
        definition: The contact information for the sponsor's representative who can
          advise on specific trial-related medical questions or problems.
      other: ''
    repeating: 'No'
    ct: {}
    short_name: Medical Expert Contact Info
  ordinal: 37
